Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015
August 3, 2015 8:06 AM EDT
(Updated - August 3, 2015 8:07 AM EDT)
Altera Corp (NASDAQ: ALTR) announced the signing of a licensing agreement with ZMDI (Zentrum Mikroelektronik Dresden AG), a German-based analog and mixed signal semiconductor company. Altera will leverage ZMDI's world-class digital power management technology to integrate advanced multi-mode digital control (MMDC) power capabilities into Enpirion® PowerSoC devices. A design team of digital power experts will focus on expanding the control, adaptability and power saving features of Enpirion PowerSoCs to further improve the power efficiency of Altera FPGAs and SoCs.
The ZMDI digital power technology complements Altera's existing... More
August 3, 2015 8:05 AM EDT
Array Biopharma (NASDAQ: ARRY) reported Q4 EPS of ($0.09), $0.07 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $12.3 million versus the consensus estimate of $10.29 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
...
More
